Sweden: Pontus Nobréus chosen as new CEO for Redsense Medical

Spotlight Stock Market-listed, Redsense Medical, the developer of the Redsense System, which is used for monitoring blood leakage in connection with a hemodialysis treatment, has appointed Pontus Nobréus as its new CEO. Nobréus has held leading business positions in diagnostics and medtech for more than 15 years. He joins from the CEO position of Pro…

You must be a HMI Subscriber to view this content.

Subscribe Now »